BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19326438)

  • 1. The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease.
    Rife T; Rasoul B; Pullen N; Mitchell D; Grathwol K; Kurth J
    J Neurosci Res; 2009 Aug; 87(10):2319-25. PubMed ID: 19326438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a NOS1 promoter repeat with Alzheimer's disease.
    Galimberti D; Scarpini E; Venturelli E; Strobel A; Herterich S; Fenoglio C; Guidi I; Scalabrini D; Cortini F; Bresolin N; Lesch KP; Reif A
    Neurobiol Aging; 2008 Sep; 29(9):1359-65. PubMed ID: 17418914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription of human neuronal nitric oxide synthase mRNAs derived from different first exons is partly controlled by exon 1-specific promoter sequences.
    Bros M; Boissel JP; Gödtel-Armbrust U; Förstermann U
    Genomics; 2006 Apr; 87(4):463-73. PubMed ID: 16413742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal nitric oxide synthase gene polymorphism and IgE-mediated allergy in the Central European population.
    Hollá LI; Schüller M; Bucková D; Vácha J
    Allergy; 2004 May; 59(5):548-52. PubMed ID: 15080837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The untranslated region of exon 2 of the human neuronal nitric oxide synthase (NOS1) gene exerts regulatory activity.
    Bros M; Boissel JP; Gödtel-Armbrust U; Förstermann U
    Gene; 2007 Dec; 405(1-2):36-46. PubMed ID: 17949925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSPA5 promoter polymorphisms and risk of Parkinson's disease in Taiwan.
    Chen CM; Wu YR; Hu FJ; Chen YC; Chuang TJ; Cheng YF; Lee-Chen GJ
    Neurosci Lett; 2008 Apr; 435(3):219-22. PubMed ID: 18343577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls.
    Costa-Mallen P; Afsharinejad Z; Kelada SN; Costa LG; Franklin GM; Swanson PD; Longstreth WT; Viernes HM; Farin FM; Smith-Weller T; Checkoway H
    Mov Disord; 2004 Jan; 19(1):76-83. PubMed ID: 14743364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans.
    Reif A; Jacob CP; Rujescu D; Herterich S; Lang S; Gutknecht L; Baehne CG; Strobel A; Freitag CM; Giegling I; Romanos M; Hartmann A; Rösler M; Renner TJ; Fallgatter AJ; Retz W; Ehlis AC; Lesch KP
    Arch Gen Psychiatry; 2009 Jan; 66(1):41-50. PubMed ID: 19124687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function.
    Reif A; Herterich S; Strobel A; Ehlis AC; Saur D; Jacob CP; Wienker T; Töpner T; Fritzen S; Walter U; Schmitt A; Fallgatter AJ; Lesch KP
    Mol Psychiatry; 2006 Mar; 11(3):286-300. PubMed ID: 16389274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a functional NOS1 promoter repeat with Alzheimer's disease in the VITA cohort.
    Reif A; Grünblatt E; Herterich S; Wichart I; Rainer MK; Jungwirth S; Danielczyk W; Deckert J; Tragl KH; Riederer P; Fischer P
    J Alzheimers Dis; 2011; 23(2):327-33. PubMed ID: 21098972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome.
    Winkelmann J; Lichtner P; Schormair B; Uhr M; Hauk S; Stiasny-Kolster K; Trenkwalder C; Paulus W; Peglau I; Eisensehr I; Illig T; Wichmann HE; Pfister H; Golic J; Bettecken T; Pütz B; Holsboer F; Meitinger T; Müller-Myhsok B
    Mov Disord; 2008 Feb; 23(3):350-8. PubMed ID: 18058820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease.
    Parsian A; Sinha R; Racette B; Zhao JH; Perlmutter JS
    Parkinsonism Relat Disord; 2004 Jun; 10(4):213-9. PubMed ID: 15120095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal NO synthase (NOS1) is a major candidate gene for asthma.
    Grasemann H; Yandava CN; Drazen JM
    Clin Exp Allergy; 1999 Dec; 29 Suppl 4():39-41. PubMed ID: 10641565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.
    Hadjigeorgiou GM; Xiromerisiou G; Gourbali V; Aggelakis K; Scarmeas N; Papadimitriou A; Singleton A
    Mov Disord; 2006 Apr; 21(4):534-9. PubMed ID: 16250025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of tau gene polymorphism with Parkinson's disease.
    Zappia M; Annesi G; Nicoletti G; Serra P; Arabia G; Pugliese P; Messina D; Caracciolo M; Romeo N; Annesi F; Pasqua AA; Spadafora P; Civitelli D; Romeo N; Epifanio A; Morgante L; Quattrone A
    Neurol Sci; 2003 Oct; 24(3):223-4. PubMed ID: 14600827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population.
    Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ
    Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients.
    Bialecka M; Klodowska-Duda G; Kurzawski M; Slawek J; Gorzkowska A; Opala G; Bialecki P; Sagan L; Droździk M
    Parkinsonism Relat Disord; 2008 Dec; 14(8):636-40. PubMed ID: 18362084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PITX3 polymorphism is associated with early onset Parkinson's disease.
    Bergman O; Håkansson A; Westberg L; Nordenström K; Carmine Belin A; Sydow O; Olson L; Holmberg B; Eriksson E; Nissbrandt H
    Neurobiol Aging; 2010 Jan; 31(1):114-7. PubMed ID: 18420308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females.
    Lin JJ; Chen CH; Yueh KC; Chang CY; Lin SZ
    Parkinsonism Relat Disord; 2006 Jan; 12(1):9-13. PubMed ID: 16337421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
    Mellick GD; Maraganore DM; Silburn PA
    Neurosci Lett; 2005 Feb; 375(2):112-6. PubMed ID: 15670652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.